Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
06/1995
06/22/1995WO1995016691A1 Rapamycin derivatives useful as immunosuppressants
06/22/1995WO1995016689A1 IMPROVED PROCESS FOR THE SYNTHESIS OF 2-AMINO-3,5-DIHYDRO-7-SUBSTITUTED-4H-PYRROLO[3,2-d]PYRIMIDIN-4-ONES
06/22/1995WO1995016688A1 Hiv protease inhibitors
06/22/1995WO1995016687A1 Platelet activating factor antagonists: imidazopyridine indoles
06/22/1995WO1995016679A1 Morpholine and thiomorpholine tachykinin receptor antagonists
06/22/1995WO1995016672A1 Vitamin d amine and amide derivatives
06/22/1995WO1995016464A1 Controlled release of pharmaceutically active substances for immunotherapy
06/22/1995WO1995016462A1 Method for antigen-specific immunoregulation by t-cell alpha chain
06/22/1995WO1995016452A2 Use of macrophage depleting agents for prolonging the survival of non-autologus hematopoietic cell transplants and animal model assay systems
06/22/1995WO1995016437A1 Method of transmitting a biologically active material to a cell
06/22/1995WO1995010271A3 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
06/22/1995WO1995007992A3 Cloned glutamic acid decarboxylase
06/22/1995CA2179018A1 Method for antigen-specific immunoregulation by t-cell alpha chain
06/22/1995CA2178902A1 Controlled release of pharmaceutically active substances for immunotherapy
06/22/1995CA2178090A1 Vitamin d amine and amide derivatives
06/22/1995CA2176247A1 Platelet activating factor antagonists: imidazopyridine indoles
06/22/1995CA2176040A1 Improved process for the synthesis of 2-amino-3,5-dihydro-7-substituted-4h-pyrrolo[3,2-d]pyrimidin-4-ones
06/22/1995CA2174729A1 A method of preventing depletion of non-autologous hematopoietic cells and animal model systems for use thereof
06/22/1995CA2138638A1 Branched-amino-substituted thiazoles, processes for their preparation and the pharmaceutical compositions which contain them
06/22/1995CA2138513A1 Methods of inhibiting myeloperoxidase activity
06/22/1995CA2138509A1 Methods of inhibiting autoimmune diseases
06/22/1995CA2138492A1 Methods of increasing macrophage function
06/22/1995CA2138457A1 Non-peptide tachykinin receptor antagonists
06/21/1995EP0658624A2 Recombinant genes expressing pp14
06/21/1995EP0658559A1 Thienothiazin derivatives, process for their preparation and their use as 5-dipoxygenase and cyclooxygenase inhibitors
06/21/1995EP0658113A1 Isolated nonapeptide derived from mage-3 gene and presented by hla-a1, and uses thereof
06/21/1995EP0658110A1 Use of norastemizole for the treatment of allergic disorders
06/21/1995EP0552292B1 Substituted imidazobenzazepines and imidazopyridoazepines
06/21/1995CN1103782A Anti-allergic pharmaceutical composition for ophthalmic topical admini stration
06/21/1995CN1028998C Sialic acid sugar radical cholesterol process for preparing them and drug containing them for treating neuronosis
06/21/1995CN1028961C Pharmaceutical solution
06/20/1995US5426197 Antiinflammatory, antiallergy or antitumor agents
06/20/1995US5426119 Thromboxane antagonists
06/20/1995US5426107 Pyrazolopyrimidinone antianginal agents
06/15/1995WO1995016038A2 Humanized antibodies and uses thereof
06/15/1995WO1995016033A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY
06/15/1995WO1995015979A1 Pretargeting methods and compounds
06/15/1995WO1995015976A1 Nucleic acids encoding a house dust mite allergen, der p iii, and uses therefor
06/15/1995WO1995015959A1 Tricyclic derivatives and their use in pharmaceuticals
06/15/1995WO1995015953A1 Novel substituted oxazolidines
06/15/1995WO1995015949A1 Tricyclic derivatives and their use in pharmaceuticals
06/15/1995WO1995015947A1 Anthracene spiro-pyrrolidines as immuno-modulators
06/15/1995WO1995015946A1 Piperazine-substituted pyrroloanthracene as immuno-moderators
06/15/1995WO1995015945A1 Substituted pyrroloanthracenes and pyrroloanthracene diones as immunomodulators
06/15/1995WO1995015939A1 Tricyclic derivatives, pharmaceutical compositions containing them
06/15/1995WO1995015758A1 Aryl and heteroaryl quinazoline compounds which inhibit csf-1r receptor tyrosine kinase
06/15/1995WO1995015749A1 Cysteine protease inhibitors containing heterocyclic leaving groups
06/15/1995CA2178622A1 Humanized antibodies and uses thereof
06/15/1995CA2178476A1 Pretargeting methods and compounds
06/15/1995CA2177495A1 Cysteine protease inhibitors containing heterocyclic leaving groups
06/15/1995CA2176825A1 C5a receptor antagonists having substantially no agonist activity
06/15/1995CA2137976A1 Thienothiazine derivatives
06/14/1995EP0657468A1 Human stromae derived factor
06/14/1995EP0657175A2 Vaccine comprising autologous epidermal growth factor and use thereof
06/14/1995EP0657169A1 Fruit polyphenol; process for production thereof; and antioxidant, hypotensive agent, antimutagenic agent, antiallergic agent and anticariogenic agent, each comprising said polyphenol
06/14/1995EP0656947A1 Human interleukin-13
06/14/1995EP0656946A1 Immunoglobulins devoid of light chains
06/14/1995EP0656906A1 A novel endothelial cell molecule mediating lymphocyte binding in man
06/14/1995EP0656844A1 Crank mechanism for a windscreen wiper drive of a motor vehicle.
06/14/1995EP0656789A1 Method for treating a lfa-1-mediated disorder
06/14/1995EP0656778A1 ENANTIOMERICALLY PURE $g(b)-D-DIOXOLANE-NUCLEOSIDES
06/14/1995EP0656773A1 Use of radical catchers as immunomodulating agents in cosmetic and dermatological compositions.
06/14/1995EP0525111B1 Antiinflammatory hydroxamic acids and n-hydroxyureas
06/14/1995EP0494260B1 Granulocyte-colony stimulating factor receptors
06/14/1995EP0483223B1 Enhanced lak cell activation by treatment of human peripheral blood mononuclear cells with amino acid amides
06/14/1995CN1028863C 3-cycloalkyl-prop-2-enamide derivatives
06/13/1995US5424447 Inhibitors of nitric oxide formation from arginine
06/13/1995US5424308 Immunomodulating agents
06/13/1995US5424287 A pure protein-based extract prepared by alkaline extraction a bacterial suspension at a PH between 11 to 13; stimulants for production of prostaglandins, anticarcinogenic agents; immunology
06/13/1995CA1335892C Saccharide derivatives
06/13/1995CA1335883C Enhancement of the cellular immune response
06/09/1995CA2136590A1 Recombinant genes expressing pp14
06/08/1995WO1995015384A1 Vector, viral protein, nucleotide sequence coding therefor and method for inhibiting immune recognition
06/08/1995WO1995015339A1 Antagonists to chaperonin 10
06/08/1995WO1995015338A1 Chaperonin 10
06/08/1995WO1995015311A1 Tachykinin antagonists
06/08/1995WO1995015309A1 Dp-iv-serine protease inhibitors
06/08/1995WO1995015179A1 Method of treating intestinal disorders
06/08/1995WO1995015173A1 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
06/08/1995WO1995015171A1 A 46 Kd HUMAN MILK FAT GLOBULE ANTIGEN
06/08/1995WO1995013071A3 Treatment of immunoregulatory disorders
06/08/1995DE4421433C1 Transdermal therapeutic system for treatment of, e.g., hypertension
06/08/1995CA2178066A1 Dp-iv-serine protease inhibitors
06/08/1995CA2177994A1 Tachykinin antagonists
06/08/1995CA2177991A1 A 46 kd human milk fat globule antigen
06/08/1995CA2177825A1 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
06/08/1995CA2177699A1 Vector, viral protein, nucleotide sequence coding therefor and method for inhibiting immune recognition
06/08/1995CA2177570A1 Method of treating intestinal disorders
06/07/1995EP0656213A1 Treatment of conditions and disease
06/07/1995EP0656212A1 Liquid compositions containing cyclosporin and process for their preparation
06/07/1995EP0656061A1 Novel glycoforms of soluble complement receptor 1
06/07/1995EP0655996A1 Substituted benzylamino nitrogen containing non-aromatic heterocycles
06/07/1995EP0655921A1 Novel glucan preparation
06/07/1995EP0655919A1 Treatment of human viral infections
06/07/1995CN1103402A Substituted pyrroles
06/07/1995CN1028760C Process for preparing sequence of antidirection direction, antimessenger RNA oligonuclectides of alpha TNF
06/07/1995CN1028757C Process for preparing heterocyclic derivatives
06/06/1995US5422359 α-aminoketone derivatives
06/06/1995US5422351 Antiallergens; antiinflammatory agents
06/06/1995CA1335792C Method and dosage form using an antagonist to gamma interferon to control mhc-associated autoimmune disease
1 ... 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 ... 1172